Zobrazeno 1 - 10 of 88 pro vyhledávání: '"Hennerici W"'
1
Akademický článek
Insights into the Therapeutic Potential of Active Ingredients of Citri Reticulatae Pericarpium in Combatting Sarcopenia: An In Silico Approach.
Autor: Ullah, Amin1 (AUTHOR), Bo, Yacong1 (AUTHOR), Li, Jiangtao2 (AUTHOR), Li, Jinjie2 (AUTHOR), Khatun, Pipasha1 (AUTHOR), Lyu, Quanjun1 (AUTHOR) lqjnutr@zzu.edu.cn, Kou, Guangning1,2 (AUTHOR) lqjnutr@zzu.edu.cn
Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11451. 22p.
Zobrazit plný text záznamu
2
Akademický článek
Incretin combination therapy for the treatment of non-alcoholic steatohepatitis.
Autor: Kannt A; Sanofi Research and Development, Frankfurt, Germany.; Experimental Pharmacology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Branch for Translational Medicine and Pharmacology TMP, Frankfurt, Germany., Madsen AN; Gubra, Horsholm, Denmark., Kammermeier C; Sanofi Research and Development, Frankfurt, Germany., Elvert R; Sanofi Research and Development, Frankfurt, Germany., Klöckener T; Sanofi Research and Development, Frankfurt, Germany., Bossart M; Sanofi Research and Development, Frankfurt, Germany., Haack T; Sanofi Research and Development, Frankfurt, Germany., Evers A; Sanofi Research and Development, Frankfurt, Germany., Lorenz K; Sanofi Research and Development, Frankfurt, Germany., Hennerici W; Sanofi Research and Development, Frankfurt, Germany., Rocher C; Sanofi Research and Development, Chilly-Mazarin Cedex, France., Böcskei Z; Sanofi Research and Development, Chilly-Mazarin Cedex, France., Guillemot JC; Sanofi Research and Development, Chilly-Mazarin Cedex, France., Mikol V; Sanofi Research and Development, Chilly-Mazarin Cedex, France., Pattou F; Univ Lille, Inserm, CHU Lille, Institut Pasteur de Lille, UMR1011-EGID, Lille, France., Staels B; Univ Lille, Inserm, CHU Lille, Institut Pasteur de Lille, UMR1011-EGID, Lille, France., Wagner M; Sanofi Research and Development, Frankfurt, Germany.
Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Aug; Vol. 22 (8), pp. 1328-1338. Date of Electronic Publication: 2020 Apr 12.
Zobrazit plný text záznamu
3
Akademický článek
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice.
Autor: Schmoll D; Sanofi R&D Frankfurt Germany., Ziegler N; Sanofi R&D Frankfurt Germany., Viollet B; Université de Paris Institut Cochin CNRS UMR 8104 INSERM U1016 Paris France., Foretz M; Université de Paris Institut Cochin CNRS UMR 8104 INSERM U1016 Paris France., Even PC; UMR Nutrition Physiology and Ingestive Behavior AgroParisTech INRA Université Paris-Saclay Paris France., Azzout-Marniche D; UMR Nutrition Physiology and Ingestive Behavior AgroParisTech INRA Université Paris-Saclay Paris France., Nygaard Madsen A; Gubra Hørsholm Denmark., Illemann M; Gubra Hørsholm Denmark., Mandrup K; Gubra Hørsholm Denmark., Feigh M; Gubra Hørsholm Denmark., Czech J; Sanofi R&D Frankfurt Germany., Glombik H; Sanofi R&D Frankfurt Germany., Olsen JA; Sanofi R&D Frankfurt Germany., Hennerici W; Sanofi R&D Frankfurt Germany., Steinmeyer K; Sanofi R&D Frankfurt Germany., Elvert R; Sanofi R&D Frankfurt Germany., Castañeda TR; Sanofi R&D Frankfurt Germany., Kannt A; Sanofi R&D Frankfurt Germany.; Institute of Experimental Pharmacology Medical Faculty Mannheim University of Heidelberg Mannheim Germany.; Fraunhofer IME Translational Medicine and Pharmacology Frankfurt Germany.
Publikováno v: Hepatology communications [Hepatol Commun] 2020 May 15; Vol. 4 (7), pp. 1056-1072. Date of Electronic Publication: 2020 May 15 (Print Publication: 2020).
Zobrazit plný text záznamu
4
Akademický článek
Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys.
Autor: Elvert R; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Bossart M; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Herling AW; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Weiss T; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Zhang B; Sanofi Asia Pacific R&D, Shanghai, China., Kannt A; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German.; Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Wagner M; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Haack T; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Evers A; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Dudda A; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Keil S; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Lorenz M; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Lorenz K; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Riz M; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Hennerici W; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German., Larsen PJ; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, German.
Publikováno v: Endocrinology [Endocrinology] 2018 Aug 01; Vol. 159 (8), pp. 3105-3119.
Zobrazit plný text záznamu
5
Akademický článek
High throughput screening of mitochondrial bioenergetics in human differentiated myotubes identifies novel enhancers of muscle performance in aged mice.
Autor: Biesemann N; R&D Immunology & Inflammation Therapeutic Area, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany. nadine.biesemann@sanofi.com., Ried JS; R&D Immunology & Inflammation Therapeutic Area, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany., Ding-Pfennigdorff D; R&D Immunology & Inflammation Therapeutic Area, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany., Dietrich A; R&D TMED Bioinformatics, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany., Rudolph C; R&D Integrated Drug Discovery, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany., Hahn S; R&D Clinical Science Operations, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany., Hennerici W; R&D Clinical Science Operations, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany., Asbrand C; R&D Immunology & Inflammation Therapeutic Area, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany., Leeuw T; R&D Immunology & Inflammation Therapeutic Area, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany., Strübing C; R&D Immunology & Inflammation Therapeutic Area, Sanofi, Industriepark Hoechst, 65926, Frankfurt am Main, Germany. carsten.struebing@sanofi.com.
Publikováno v: Scientific reports [Sci Rep] 2018 Jun 20; Vol. 8 (1), pp. 9408. Date of Electronic Publication: 2018 Jun 20.
Zobrazit plný text záznamu
6
Akademický článek
Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature.
Autor: Chrysavgis, Lampros G.1 (AUTHOR) lchrisaugis@gmail.com, Kazanas, Spyridon1 (AUTHOR) sp.kazanas@gmail.com, Bafa, Konstantina1 (AUTHOR) konstantina.mpaf@gmail.com, Rozani, Sophia1 (AUTHOR) sofrozan@gmail.com, Koloutsou, Maria-Evangelia2 (AUTHOR) mkoloutsou@yahoo.com, Cholongitas, Evangelos1 (AUTHOR) echolog@med.uoa.gr
Publikováno v: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3832. 28p.
Zobrazit plný text záznamu
7
Akademický článek
Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer's Disease.
Autor: Babylon, Lukas1 (AUTHOR) lukas.babylon@ernaehrung.uni-giessen.de, Meißner, Julia1 (AUTHOR), Eckert, Gunter P.1 (AUTHOR) eckert@uni-giessen.de
Publikováno v: International Journal of Molecular Sciences. Jun2023, Vol. 24 Issue 12, p10029. 12p.
Zobrazit plný text záznamu
8
Akademický článek
Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes.
Autor: Ma, Zijun1 (AUTHOR), Jin, Kaiqin2 (AUTHOR), Yue, Mengmeng1 (AUTHOR), Chen, Xin1 (AUTHOR), Chen, Jun1 (AUTHOR)
Publikováno v: Journal of Diabetes Research. 4/15/2023, p1-8. 8p.
Zobrazit plný text záznamu
9
Akademický článek
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives.
Autor: Nevola, Riccardo1 (AUTHOR), Epifani, Raffaella1 (AUTHOR), Imbriani, Simona1 (AUTHOR), Tortorella, Giovanni1 (AUTHOR), Aprea, Concetta1 (AUTHOR), Galiero, Raffaele1 (AUTHOR), Rinaldi, Luca1 (AUTHOR), Marfella, Raffaele1 (AUTHOR), Sasso, Ferdinando Carlo1 (AUTHOR) ferdinandocarlo.sasso@unicampania.it
Publikováno v: International Journal of Molecular Sciences. Jan2023, Vol. 24 Issue 2, p1703. 25p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje